Tone mix
Week by week 52 weeks
Share of United Therapeutics Corp's 343 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Sep 21, 2026 · tone -66FinancialContent - Why United Therapeutics (UTHR) Shares Are Falling Today-70
- Week of Mar 23, 2026 · tone +100United Therapeutics (NASDAQ:UTHR) Price Target Raised to $486.00+68
- Week of Jun 29, 2026 · tone +71United Therapeutics Buys Thymmune Therapeutics+54
- Week of Jan 19, 2026 · tone +66United Therapeutics Corporation (NASDAQ:UTHR) Receives $509.50 Average Price Target from Analysts+48
- Week of May 4, 2026 · tone -17United Therapeutics Corp Q1 Income Declines-48
- Week of Jul 20, 2026 · tone -33Boehringer Alleges United Therapeutics Poached Staff, Secrets-44
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about United Therapeutics Corp in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 10 | +63 |
| Last 30 sessions | 44 | +26 |
| Last 90 sessions | 112 | +16 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.rttnews.com · 1 outletUnited Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH TherapyPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| United Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH Therapy | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.finanzen.ch · 1 outletUnited Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH TherapyPositive
- www.themarketsdaily.com · 1 outletInsider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,592,080.00 in StockNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| United Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH Therapy | www.finanzen.ch | 1 | Positive |
| Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,592,080.00 in Stock | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
2 headlines, average tone +49: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.postbulletin.com · 1 outletUnited Therapeutics to build a $9 million hangar at Rochester's airportPositive
- www.themarketsdaily.com · 1 outletCritical Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) versus United Therapeutics (NASDAQ:UTHR)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| United Therapeutics to build a $9 million hangar at Rochester's airport | www.postbulletin.com | 1 | Positive |
| Critical Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) versus United Therapeutics (NASDAQ:UTHR) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
2 headlines, average tone +79: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.rttnews.com · 1 outletUnited Therapeutics Authorizes Additional $2 Billion Share Buyback ProgramPositive
- www.tickerreport.com · 1 outletShare Repurchase Plan Announced by United Therapeutics (NASDAQ:UTHR) Board of DirectorsPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| United Therapeutics Authorizes Additional $2 Billion Share Buyback Program | www.rttnews.com | 1 | Positive |
| Share Repurchase Plan Announced by United Therapeutics (NASDAQ:UTHR) Board of Directors | www.tickerreport.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletUnited Therapeutics (NASDAQ:UTHR) Price Target Raised to $725.00Positive
- www.themarketsdaily.com · 1 outletUnited Therapeutics Corporation $UTHR Shares Purchased by Robeco Institutional Asset Management B.V.Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| United Therapeutics (NASDAQ:UTHR) Price Target Raised to $725.00 | www.dailypolitical.com | 1 | Positive |
| United Therapeutics Corporation $UTHR Shares Purchased by Robeco Institutional Asset Management B.V. | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about United Therapeutics Corp, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.